Lisocabtagene maraleucel as second-line therapy in adults with relapsed or refractory large B-cell lymphoma who were not intended for haematopoietic stem cell transplantation (PILOT): an open-label, phase 2 study
Alison R. Sehgal, Daanish Hoda, Peter A. Riedell, Nilanjan Ghosh, Mehdi Hamadani, Gerhard Hildebrandt, John E. Godwin, Patrick M. Reagan, Nina D. Wagner‐Johnston, James Essell, Rajneesh Nath, Scott R. Solomon, Rebecca Champion, Edward Licitra, Suzanne Fanning, Neel K. Gupta, Ronald L. Dubowy, Aleco D’Andrea, Lei Wang, K. OGASAWARA, Jerill Thorpe, Leo I. Gordon
Topics & Concepts
Refractory (planetary science)LymphomaTransplantationMedicineStem cellHaematopoiesisHematopoietic cellOncologyInternal medicineBiologyGeneticsAstrobiologyCAR-T cell therapy researchLymphoma Diagnosis and TreatmentCancer Immunotherapy and Biomarkers